A human CD22 transgenic, myc-driven lymphoma model to test effects of targeted therapies on lymphoma immune microenvironment in immunecompetent mice

Wagner F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 246-247

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Franziska Gsottberger Department of Medicine 5 – Haematology and Oncology Carolin Brandl Professur für Genetik Lars Nitschke Professur für Genetik Andreas Mackensen Lehrstuhl für Innere Medizin V Fabian Müller Department of Medicine 5 – Haematology and Oncology

How to cite

APA:

Wagner, F., Brandl, C., Petkovic, S., Emmerich, C., Nitschke, L., Mackensen, A., & Müller, F. (2019). A human CD22 transgenic, myc-driven lymphoma model to test effects of targeted therapies on lymphoma immune microenvironment in immunecompetent mice. In ONCOLOGY RESEARCH AND TREATMENT (pp. 246-247). BASEL: KARGER.

MLA:

Wagner, Franziska, et al. "A human CD22 transgenic, myc-driven lymphoma model to test effects of targeted therapies on lymphoma immune microenvironment in immunecompetent mice." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2019. 246-247.

BibTeX: Download